Cytek Biosciences Relocates European Headquarters to Amsterdam
The biotechnology firm expands its presence in the region’s growing life sciences sector.
Cytek Biosciences has officially moved its European headquarters to Amsterdam as part of a broader expansion strategy to enhance customer support and operational efficiency.
The relocation places the company at the heart of the Netherlands’ thriving life sciences district, offering greater access to research institutions and innovation hubs.
Executives say the move underscores Cytek’s commitment to growth in Europe’s biotechnology market.